Most pharmacologically relevant proteins (such as growth factors, cytokines, hormones and antibodies) are glycosylated. The correct human glycosylation and optimal sialylation of a recombinant protein are essential for its full bioactivity, half-life, stability or immunogenicity. To evaluate and realise the full therapeutic potential, Glycotope offers a broad range of state-of-the-art glycoanalytical and
glycoengineering technologies.